Coronary Stent Market is estimated to be US$ 11,158.29 million by 2030 with a CAGR of 6.9% during the forecast period

4 minutes, 56 seconds Read

The coronary stent market refers to the market for medical devices used in the treatment of coronary artery disease (CAD). Coronary stents are small, expandable tubes made of metal or polymer that are inserted into narrowed or blocked coronary arteries to restore blood flow to the heart muscle. They are commonly used in procedures such as percutaneous coronary intervention (PCI) or angioplasty.

Coronary artery disease is a condition characterized by the buildup of plaque within the arteries, leading to narrowing or blockage of the vessels. This can result in reduced blood flow to the heart, causing chest pain (angina) or potentially leading to a heart attack.

Coronary stents act as scaffolding within the arteries, supporting the vessel walls and keeping them open to allow proper blood flow. They can be either bare metal stents or drug-eluting stents (DES). Bare metal stents are made of metal alloys and provide structural support, while DES are coated with medications that help prevent restenosis (re-narrowing) of the arteries.

Here are some key highlights of the coronary stent market:

Growing Prevalence of Coronary Artery Disease (CAD): The increasing incidence of CAD worldwide is a major driver for the coronary stent market. Factors such as sedentary lifestyles, unhealthy diets, tobacco use, and aging populations contribute to the rising prevalence of CAD, creating a higher demand for coronary stents.

Technological Advancements in Stent Design: The coronary stent market has witnessed significant advancements in stent design, materials, and coatings. Drug-eluting stents (DES) with improved drug delivery systems and bioresorbable stents that gradually dissolve over time are among the innovative developments. These advancements aim to enhance patient outcomes, reduce complications, and improve long-term efficacy.

Increasing Preference for Minimally Invasive Procedures: Minimally invasive procedures, such as percutaneous coronary intervention (PCI) or angioplasty with stent placement, have become the preferred treatment approach for many patients with CAD. The benefits of shorter hospital stays, quicker recovery times, and reduced complications compared to traditional open-heart surgery have contributed to the growing adoption of coronary stents.

Rising Awareness and Screening Programs: Increased awareness of CAD and the importance of early detection and treatment have led to more screening programs, particularly among high-risk populations. This increased awareness and early intervention drive the demand for coronary stents as a primary treatment option.

Favorable Reimbursement Policies: Reimbursement policies and healthcare reforms in various countries play a crucial role in the adoption and utilization of coronary stents. Improved reimbursement coverage and policies that support cost-effective stent utilization have positively impacted market growth.

Focus on Patient Safety and Long-Term Outcomes: Manufacturers and healthcare providers are emphasizing patient safety and long-term outcomes in coronary stent procedures. This focus includes reducing complications such as restenosis and thrombosis, improving stent efficacy, and optimizing patient follow-up care.

Emerging Markets and Increased Access to Healthcare: Growing economies and improving healthcare infrastructure in emerging markets contribute to the expansion of the coronary stent market. Increased access to healthcare facilities, rising disposable incomes, and government initiatives to address cardiovascular diseases drive market growth in these regions.

Request a sample or make an inquiry by clicking the following link:

Coronary Stent Market, By Product Type (Drug-Eluting Stent, Bare-Metal Stent, and Bioresorbable Vascular Stent), By Material Type (Metallic, Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium, and Others), By End-User (Hospitals, Cardiac Center, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030

The coronary stent market can be segmented based on various factors. Here are some common segmentation approaches:

By Product Type:

Drug-Eluting Stents (DES): These stents are coated with medications (such as anti-proliferative drugs) that help prevent restenosis.

Bare Metal Stents (BMS): These stents are made of metal alloys and provide structural support to the arteries.

Bioresorbable Stents: These stents are designed to gradually dissolve over time, reducing the long-term presence of a permanent implant.

By Material Composition:

Metal Stents: These stents are made of metal alloys such as stainless steel, cobalt-chromium, or platinum-chromium.

Polymer Stents: These stents are made of biocompatible polymers that provide the necessary support to the artery.

By End User:

Hospitals and Cardiac Centers: These facilities perform procedures like angioplasty and stent implantation for patients with coronary artery disease.

Ambulatory Surgical Centers: These centers provide outpatient cardiac interventions, including stent implantation, in a less invasive setting.

By Geography:

North America: This segment includes the United States and Canada.

Europe: This segment includes countries in the European region.

Asia Pacific: This segment includes countries in the Asia Pacific region, such as China, Japan, India, and Australia.

Latin America: This segment includes countries in Latin America, such as Brazil and Mexico.

Middle East and Africa: This segment includes countries in the Middle Eastern and African regions.

By Patient Profile:

Primary Stenting: This segment includes patients who undergo stent implantation as the primary treatment for coronary artery disease.

Complex PCI: This segment comprises patients who require more complex percutaneous coronary interventions, including multiple stents, bifurcation stenting, or chronic total occlusion (CTO) interventions.

By Application:

Coronary Artery Disease: This segment focuses on stent utilization for the treatment of coronary artery disease, including stable angina and acute coronary syndromes.

Stent Restenosis: This segment includes patients who require stent implantation for the treatment of restenosis (renarrowing) of previously implanted stents.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Related report:

To know more        

Contact Us:


Prophecy Market Insights

📞+1 860 531 2574


🌐 Website-

🌐 Blog-

Follow us on:

LinkedIn | Twitter | Facebook

Your Missed